Natrilix (Indapamide)

Indapamide is indicated for conditions that involve excess fluid retention or elevated arterial pressure.

• Essential hypertension: lowers high blood pressure in patients with primary hypertension.
• Congestive heart failure‑related edema: reduces fluid accumulation associated with heart failure.
• Renal or hepatic disease‑related edema: helps manage swelling due to kidney or liver disorders.

• Indapamide acts primarily on the distal convoluted tubule of the nephron, where it blocks the Na⁺/Cl⁻ cotransporter. This inhibition decreases sodium and chloride reabsorption, leading to increased urinary excretion of water and electrolytes, which reduces plasma volume. Additionally, indapamide induces direct vasodilation of arterioles, contributing further to blood‑pressure reduction. The combined diuretic and vasodilatory actions produce a sustained antihypertensive effect without significant activation of the renin‑angiotensin system.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Electrolyte imbalance: reduced potassium or sodium levels that may cause muscle cramps or weakness.
• Increased urination: more frequent or larger volume urine output, especially during the first weeks of treatment.
• Dizziness or light‑headedness: feeling faint or unsteady when standing up quickly.
• Fatigue: persistent tiredness or lack of energy reported by some patients.
• Severe dehydration: marked fluid loss leading to low blood pressure and possible fainting.
• Acute kidney injury: sudden decline in renal function that may require medical evaluation.
• Allergic reactions: rash, itching, or swelling of the face, lips, or throat indicating hypersensitivity.

When prescribing indapamide, clinicians should consider several precautionary measures to ensure safe use.

• Monitor electrolytes: check serum potassium and sodium regularly during therapy.
• Assess renal function: evaluate kidney performance before initiation and periodically thereafter.
• Evaluate blood pressure: avoid excessive hypotension, especially in patients on other antihypertensives.
• Caution in diabetes: monitor blood glucose as indapamide may raise glucose levels.
• Avoid use in severe hepatic impairment: risk of accumulation and toxicity.
• Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture.

Indapamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Lithium: concurrent use may increase lithium levels and risk toxicity.
• NSAIDs: may reduce diuretic effect and worsen renal function.
• ACE inhibitors or ARBs: combined therapy can cause significant potassium elevation.

Moderate Interactions (Monitor Closely)

• Antidiabetic drugs: indapamide may raise blood glucose, requiring dose adjustment.
• Other antihypertensives: additive blood‑pressure lowering effect may cause hypotension.
• Corticosteroids: may enhance sodium loss and electrolyte disturbances.